GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,740,000 | +0.8% | 39,977 | +0.8% | 0.40% | +14.0% |
| Q1 2022 | $1,727,000 | +2.9% | 39,646 | +4.2% | 0.35% | +5.1% |
| Q4 2021 | $1,678,000 | +15.3% | 38,055 | -0.1% | 0.33% | +5.4% |
| Q3 2021 | $1,455,000 | -24.3% | 38,089 | -21.0% | 0.32% | -22.4% |
| Q2 2021 | $1,921,000 | +128.4% | 48,242 | +104.6% | 0.41% | +119.5% |
| Q1 2021 | $841,000 | +4.5% | 23,574 | +7.8% | 0.18% | -3.1% |
| Q4 2020 | $805,000 | +2.4% | 21,870 | +4.7% | 0.19% | -12.0% |
| Q3 2020 | $786,000 | -10.5% | 20,883 | -3.0% | 0.22% | -14.2% |
| Q2 2020 | $878,000 | +7.3% | 21,535 | -0.3% | 0.25% | -6.3% |
| Q1 2020 | $818,000 | -19.1% | 21,593 | +0.4% | 0.27% | +2.7% |
| Q4 2019 | $1,011,000 | +9.5% | 21,517 | -0.5% | 0.26% | +3.1% |
| Q3 2019 | $923,000 | +8.2% | 21,630 | +1.5% | 0.26% | +5.4% |
| Q2 2019 | $853,000 | -3.8% | 21,317 | +0.4% | 0.24% | -4.3% |
| Q1 2019 | $887,000 | +10.6% | 21,228 | +1.1% | 0.25% | -4.2% |
| Q4 2018 | $802,000 | – | 20,997 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |